Refuge Biotech Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 29
Employees
  • Latest Deal Type
  • Debt - PPP
  • Latest Deal Amount
  • $628K
Latest Deal Amount
  • Investors
  • 8

Refuge Biotech General Information

Description

Developer of cell therapies intended to fight cancer. The company is a cancer immunotherapy company leveraging synthetic biology and gene engineering to unlock the full promise of cell therapies, and create cell therapies that sense their surroundings and conditionally activate or repress multiple genes simultaneously - resulting in more potent and targeted treatments beyond a single target and function, enabling physicians to treat cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 1505 Adams Drive
  • Suite D
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Refuge Biotech Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Refuge Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Debt - PPP 15-Apr-2020 $628K 000.00 Completed Startup
3. Early Stage VC (Series B) 02-May-2018 0000 000.00 000.00 Completed Startup
2. Early Stage VC (Series A) 05-Aug-2016 $8.9M $9.5M 000.00 Completed Startup
1. Seed Round 30-Oct-2015 $600K $600K Completed Startup
To view Refuge Biotech’s complete valuation and funding history, request access »

Refuge Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A2 3,633,084 $0.000010 8% $2.45 $2.45 1x $2.45 19.57%
Series A1 441,420 $0.000010 8% $1.36 $1.36 1x $1.36 2.38%
To view Refuge Biotech’s complete cap table history, request access »

Refuge Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cell therapies intended to fight cancer. The company is a cancer immunotherapy company leveraging synthetic
Biotechnology
Menlo Park, CA
29 As of 2020
000.00
000000000 - 000.00

0000000

et, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
0000 000000000
Philadelphia, PA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

00000000

ugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia dese
0000000000000
Tucson, AZ
00 As of 0000
000.00
0000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Refuge Biotech Competitors (59)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Carisma Therapeutics Venture Capital-Backed Philadelphia, PA 00 00000 00000000000 00000
000000000 Formerly VC-backed Tucson, AZ 00 000.00 000000&0 000.00
000 00000000000000 Venture Capital-Backed Philadelphia, PA 00 0000 00000000000 0000
000000 00000000000 Formerly VC-backed Burlingame, CA 00 00000 000000 - 000 00000
000000 Venture Capital-Backed Utrecht, Netherlands 00 00.000 000000000000 00.000
You’re viewing 5 of 59 competitors. Get the full list »

Refuge Biotech Executive Team (6)

Name Title Board Seat Contact Info
Bing Wang Ph.D Co-Founder, Chief Executive Officer, Chief Financial Officer & Board Member
Ida Louie Senior Director, Finance & Operations
Jing Zhao Chief Business Officer
David Parkinson MD Co-Founder & Chairman
Stanley Qi Ph.D Co-Founder
You’re viewing 5 of 6 executive team members. Get the full list »

Refuge Biotech Board Members (6)

Name Representing Role Since
Bing Wang Ph.D Refuge Biotech Co-Founder, Chief Executive Officer, Chief Financial Officer & Board Member 000 0000
Cuiping Gu Ph.D Sequoia Capital China Board Member 000 0000
David Parkinson MD Refuge Biotech Co-Founder & Chairman 000 0000
Karen Liu Ph.D 3E Bioventures Capital Board Member 000 0000
Scott Smith Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Refuge Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Refuge Biotech Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3Sbio Corporation Minority 000 0000 000000 0
DHVC Venture Capital Minority 000 0000 000000 0
Oceanpine Healthcare Fund Venture Capital Minority 000 0000 000000 0
Sangel Capital Venture Capital Minority 000 0000 000000 0
Sequoia Capital China Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »